Lv3
296 积分 2023-07-28 加入
Curative Application of Immunotherapy in Untreated Head and Neck and Nasopharynx Cancer
1天前
已完结
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma
1天前
已完结
Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
1天前
已完结
Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma
1个月前
已完结
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial
1个月前
已完结
Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
1个月前
已完结
Combined PD-1/VEGFR Blockade: A New Era of Treatment for Hepatocellular Cancer
1个月前
已完结
A Pilot Study of Anlotinib as a Combination Treatment in Advanced Nasopharyngeal Carcinoma
1个月前
已完结
Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor
3个月前
已完结
Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study
3个月前
已完结
皖公网安备34019202002308
